Study of Foam Sclerotherapy Versus Ambulatory Phlebectomy
Launched by IMPERIAL COLLEGE LONDON · Jan 24, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different treatments for varicose veins: foam sclerotherapy and ambulatory phlebectomy. Varicose veins are swollen veins that can cause discomfort and other issues. In this study, patients will be randomly assigned to receive one of the two treatments after their saphenous vein has been treated. Researchers will compare the effectiveness, safety, and overall patient experience of each method, as well as how much each treatment costs.
To participate, you need to be at least 18 years old and have specific symptoms related to your varicose veins. You also need to have a certain type of vein reflux, which means your blood isn't flowing properly through your veins. People with certain conditions, like deep vein thrombosis or previous varicose veins that keep coming back, won't be eligible. If you join the study, you can expect to receive one of the treatments and provide feedback through questionnaires. Your participation will help doctors understand which treatment might be better for patients with varicose veins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults over 18 years of age
- • Symptomatic GSV or SSV vein reflux \> 0.5 seconds on colour Duplex
- • Varicose vein tributary requiring treatment
- Exclusion Criteria:
- • Current DVT
- • Recurrent varicose veins
- • Arterial disease (ABPI\<0.8)
- • Vein diameter \< 3mm
- • Preference for one of the treatment options
- • Patient who are unwilling to participate
- • Inability or unwillingness to complete questionnaires
- • Inability to attend follow-up appointments
- • Patient currently included in a study of varicose vein treatment
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials